Design, synthesis and evaluation of phthalazinone thiohydantoin-based derivative as potent PARP-1 inhibitors

Add time:08/26/2019    Source:sciencedirect.com

Two new series of compounds were designed and synthesized as potent PARP-1 inhibitors. These compounds were evaluated for PARP-1 enzyme and cellular inhibitory activities. All efforts lead to the identification of 9k (named as LG-12) with efficient potency both for PARP-1 and BRCA1 deficient MDA-MB-436 cells. Additionally, the novel PARP-1 inhibitor LG-12 is an efficient chemosensitizer, which could potentiate the anti-cancer effect of TMZ. Our data presented herein provide a comprehensive preclinical in vitro evaluation of the potential therapeutic efficacy and potency of chemotherapeutic agent-PARP-1 inhibitor combinations for LG-12. The combined results indicated that LG-12 could be a promising candidate for further study.

We also recommend Trading Suppliers and Manufacturers of 1-METHYL-1H-IMIDAZOLE-4-SULFONAMIDE (cas 111124-90-4). Pls Click Website Link as below: cas 111124-90-4 suppliers

Prev:Catalytic dehydrocoupling of thienyl/furyl-substituted carbosilanes – Synthesis and characterization of functional poly(hydrosilane)s [RMe2Si(CH2)xSiH]n, (R = 2-Th, 4-Me-2-Th, 2-Fu, 5-Me-2-Fu; x = 2 and 3)
Next:Research paperDesign, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists)